Macapinlac HA - Search Results

1

FDG PET and PET/CT imaging in lymphoma and melanoma.

Macapinlac HA. Macapinlac HA. Cancer J. 2004 Jul-Aug;10(4):262-70. doi: 10.1097/00130404-200407000-00007. Cancer J. 2004. PMID: 15383207 Review.

2

Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.

Nuñez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM. Nuñez R, et al. Among authors: macapinlac ha. J Nucl Med. 2002 Jan;43(1):46-55. J Nucl Med. 2002. PMID: 11801702 Free article.

3

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.

Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D. Gayed I, et al. Mol Imaging Biol. 2003 Jan-Feb;5(1):26-31. doi: 10.1016/s1536-1632(03)00036-2. Mol Imaging Biol. 2003. PMID: 14499159

4

The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.

Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, Podoloff D. Gayed I, et al. J Nucl Med. 2004 Jan;45(1):17-21. J Nucl Med. 2004. PMID: 14734662 Free article. Clinical Trial.

5

The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma.

Macapinlac HA. Macapinlac HA. Mol Imaging Biol. 2004 Jul-Aug;6(4):200-7. doi: 10.1016/j.mibio.2004.04.002. Mol Imaging Biol. 2004. PMID: 15262235 Review.

6

Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT.

Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, Podoloff DA, Macapinlac HA. Truong MT, et al. Among authors: macapinlac ha. AJR Am J Roentgenol. 2004 Oct;183(4):1127-32. doi: 10.2214/ajr.183.4.1831127. AJR Am J Roentgenol. 2004. PMID: 15385319

7

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.

Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB Jr, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Swisher SG, et al. Cancer. 2004 Oct 15;101(8):1776-85. doi: 10.1002/cncr.20585. Cancer. 2004. PMID: 15386332 Free article.

8

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.

Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Swisher SG, et al. Ann Thorac Surg. 2004 Oct;78(4):1152-60; discussion 1152-60. doi: 10.1016/j.athoracsur.2004.04.046. Ann Thorac Surg. 2004. PMID: 15464463 Review.

9

Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes.

Mawlawi O, Podoloff DA, Kohlmyer S, Williams JJ, Stearns CW, Culp RF, Macapinlac H; National Electrical Manufacturers Association. Mawlawi O, et al. J Nucl Med. 2004 Oct;45(10):1734-42. J Nucl Med. 2004. PMID: 15471842 Free article.

10

CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.

Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA. Choi H, et al. Among authors: macapinlac ha. AJR Am J Roentgenol. 2004 Dec;183(6):1619-28. doi: 10.2214/ajr.183.6.01831619. AJR Am J Roentgenol. 2004. PMID: 15547201 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters